HER2+ Early-Stage Breast Cancer with Ruth O'Regan, MD Case 1

Case Scenario 1:

• This is a post-menopausal 58-year-old female in whom a mass was discovered in her right breast during her annual mammography.
• Her gynecologist referred her to a breast surgeon; results of her biopsy revealed 3 cm ductal carcinoma
• Pathology shows: ER— & PR–, HER2 IHC 3+
• Clinical staging; T2aN1M0
• Her surgeon discussed the patient’s case at the Breast Tumor Board and it was suggested that the patient be referred to a medical oncologist for consideration of HER2-targeted neoadjuvant therapy.
• The surgeon shared his opinion with the patient who agreed to go to the medical oncologist to discuss her options.